文献
J-GLOBAL ID:202002236563926534
整理番号:20A0200036
ダブラフェニブ単剤療法を受けたBRAF V600変異型転移性黒色腫患者における長期転帰: 第2相および3回臨床試験からの分析【JST・京大機械翻訳】
Long-term outcomes in patients with BRAF V600-mutant metastatic melanoma receiving dabrafenib monotherapy: Analysis from phase 2 and 3 clinical trials
著者 (20件):
Hauschild Axel
(University Hospital Schleswig-Holstein, Kiel, Germany)
,
Ascierto Paolo A.
(Istituto Nazionale Tumori IRCCS Fondazione “G. Pascale,” Naples, Italy)
,
Schadendorf Dirk
(University Hospital of Essen, Essen, Germany)
,
Schadendorf Dirk
(German Cancer Consortium, Heidelberg, Germany)
,
Grob Jean Jacques
(Aix-Marseille University, Marseille, France)
,
Ribas Antoni
(UCLA Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA)
,
Kiecker Felix
(Charite-Universitaetsmedizin Berlin, Berlin, Germany)
,
Dutriaux Caroline
(Hopital Saint-Andre, Bordeaux, France)
,
Demidov Lev V.
(N.N. Blokhin Russian Cancer Research Center, Moscow, Russia)
,
Lebbe Celeste
(APHP Dermatology and CIC Department, Hopital Saint-Louis, INSERM U976, University Paris Diderot, Paris, France)
,
Rutkowski Piotr
(Maria Sklodowska-Curie Institute - Oncology Center, Warsaw, Poland)
,
Blank Christian U.
(The Netherlands Cancer Institute, Amsterdam, the Netherlands)
,
Gutzmer Ralf
(Hannover Medical School, Hannover, Germany)
,
Millward Michael
(University of Western Australia, Sir Charles Gairdner Hospital, Perth, WA, Australia)
,
Kefford Richard
(Westmead Hospital and Macquarie University, Sydney, NSW, Australia)
,
Haas Tomas
(Novartis Pharma AG, Basel, Switzerland)
,
D’Amelio Anthony
(Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA)
,
Gasal Eduard
(Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA)
,
Mookerjee Bijoyesh
(Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA)
,
Chapman Paul B.
(Memorial Sloan Kettering Cancer Center, New York, NY, USA)
資料名:
European Journal of Cancer
(European Journal of Cancer)
巻:
125
ページ:
114-120
発行年:
2020年
JST資料番号:
A0802C
ISSN:
0959-8049
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)